Bristol-Myers Squibb
BMY
BMY
1,639 hedge funds and large institutions have $73.8B invested in Bristol-Myers Squibb in 2017 Q3 according to their latest regulatory filings, with 128 funds opening new positions, 610 increasing their positions, 650 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,639
Holders Change
+48
Holders Change %
+3.02%
% of All Funds
40.92%
Holding in Top 10
58
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+31.82%
% of All Funds
1.45%
New
128
Increased
610
Reduced
650
Closed
65
Calls
$1.96B
Puts
$1.56B
Net Calls
+$396M
Net Calls Change
+$95.2M
Top Buyers
| 1 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
$336M |
| 2 |
Jennison Associates
New York
|
$1.71B |
| 3 |
Invesco
Atlanta,
Georgia
|
$943M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$7.76B |
| 5 |
Parnassus Investments
San Francisco,
California
|
$172M |
